Drug discovery alliances in India--indications, targets, and new chemical entities.

about

The Drug Discovery and Development Industry in India-Two Decades of Proprietary Small-Molecule R&D.Drug discovery research in India: current state and future prospects.

P2860

Q33845748-08D80A97-8DD1-49FB-AD42-84E201FDD8C1 Q33889043-D34E402F-0869-4D9D-BB7A-B6A956887C02

P2860

Drug discovery alliances in India--indications, targets, and new chemical entities.

Item

http://www.wikidata.org/entity/Q38153661

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Drug discovery alliances in India--indications, targets, and new chemical entities.

@en

type

Item

label

Drug discovery alliances in India--indications, targets, and new chemical entities.

@en

prefLabel

Drug discovery alliances in India--indications, targets, and new chemical entities.

@en

P1476

Drug discovery alliances in India--indications, targets, and new chemical entities.

@en

P2093

Edmond Differding

http://www.w3.org/2001/XMLSchema#string

P2860

Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes

Fragment-based discovery of new highly substituted 1H-pyrrolo[2,3-b]- and 3H-imidazolo[4,5-b]-pyridines as focal adhesion kinase inhibitors

Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.

Discovery of a potent and selective small molecule hGPR91 antagonist.

Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).

Diagnosing the decline in pharmaceutical R&D efficiency.

Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.

The productivity crisis in pharmaceutical R&D.

Collaboration versus outsourcing: the need to think outside the box.

Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.

P304

43-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201300341

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258056370

http://www.w3.org/2001/XMLSchema#string

P698

24136820

http://www.w3.org/2001/XMLSchema#string

P921

India

Drug discovery alliances in India--indications, targets, and new chemical entities.

about

P2860

P2860

Drug discovery alliances in India--indications, targets, and new chemical entities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921